Skip to main content
. 2017 Jan 19;8(1):e2565. doi: 10.1038/cddis.2016.475

Figure 3.

Figure 3

VPS15 expression in DD and GSDII muscle. (a) Immunoblot analyses of muscle biopsies for VPS15, VPS34, BECN1, GAA (in DD) and the loading control GAPDH in DD and in GSDII (b) patients. Ctrl, healthy control; ERT, biopsy after ERT; numbers, patient identifiers; I, first biopsy; II: second biopsy. (c) Densitometric analysis (percentage compared with control) of proteins normalized to GAPDH for DD and GSDII (d) patients. (e) Densitometric analysis (percentage compared with control) of GAA. The different GAA forms are specified: the inactive (110+95 kDa) and the active ones (76 and 70 kDa)